Paragonix Technologies has filed a notice of an exempt offering of securities to raise $23,678,459.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Paragonix Technologies is raising $23,678,459.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Lisa Anderson played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Paragonix Technologies
Paragonix Technologies is a rapidly growing medical device manufacturer that designs, manufactures, and sells organ transplant transport devices. Our dynamic team is committed to improving the lives of transplant patients by providing advanced technologies to ensure optimal preservation for donor organs on the journey to their ultimate recipients. Our primary offices are located in Cambridge, MA.
To learn more about Paragonix Technologies, visit http://www.paragonixtechnologies.com/
Contact:
Lisa Anderson, Chief Executive Officer
617-648-9100
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.